198 related articles for article (PubMed ID: 29434051)
1. Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study.
Schneider R; McKeever P; Kim T; Graff C; van Swieten JC; Karydas A; Boxer A; Rosen H; Miller BL; Laforce R; Galimberti D; Masellis M; Borroni B; Zhang Z; Zinman L; Rohrer JD; Tartaglia MC; Robertson J;
J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):851-858. PubMed ID: 29434051
[TBL] [Abstract][Full Text] [Related]
2. Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study.
van der Ende EL; Heller C; Sogorb-Esteve A; Swift IJ; McFall D; Peakman G; Bouzigues A; Poos JM; Jiskoot LC; Panman JL; Papma JM; Meeter LH; Dopper EGP; Bocchetta M; Todd E; Cash D; Graff C; Synofzik M; Moreno F; Finger E; Sanchez-Valle R; Vandenberghe R; Laforce R; Masellis M; Tartaglia MC; Rowe JB; Butler C; Ducharme S; Gerhard A; Danek A; Levin J; Pijnenburg YAL; Otto M; Borroni B; Tagliavini F; de Mendonça A; Santana I; Galimberti D; Sorbi S; Zetterberg H; Huang E; van Swieten JC; Rohrer JD; Seelaar H;
J Neuroinflammation; 2022 Sep; 19(1):217. PubMed ID: 36064709
[TBL] [Abstract][Full Text] [Related]
3. Altered Cerebrospinal Fluid Exosomal microRNA Levels in Young-Onset Alzheimer's Disease and Frontotemporal Dementia.
Tan YJ; Wong BYX; Vaidyanathan R; Sreejith S; Chia SY; Kandiah N; Ng ASL; Zeng L
J Alzheimers Dis Rep; 2021; 5(1):805-813. PubMed ID: 34870106
[TBL] [Abstract][Full Text] [Related]
4. CSF neurofilament light concentration is increased in presymptomatic
Rostgaard N; Roos P; Portelius E; Blennow K; Zetterberg H; Simonsen AH; Nielsen JE
Neurology; 2018 Jan; 90(2):e157-e163. PubMed ID: 29237796
[TBL] [Abstract][Full Text] [Related]
5. Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia.
Fenoglio C; Serpente M; Visconte C; Arcaro M; Sorrentino F; D'Anca M; Arighi A; Rotondo E; Vimercati R; Rossi G; Scarpini E; Galimberti D
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499048
[TBL] [Abstract][Full Text] [Related]
6. Plasma microRNA signature in presymptomatic and symptomatic subjects with
Kmetzsch V; Anquetil V; Saracino D; Rinaldi D; Camuzat A; Gareau T; Jornea L; Forlani S; Couratier P; Wallon D; Pasquier F; Robil N; de la Grange P; Moszer I; Le Ber I; Colliot O; Becker E;
J Neurol Neurosurg Psychiatry; 2021 May; 92(5):485-493. PubMed ID: 33239440
[TBL] [Abstract][Full Text] [Related]
7. A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort.
Moore K; Convery R; Bocchetta M; Neason M; Cash DM; Greaves C; Russell LL; Clarke MTM; Peakman G; van Swieten J; Jiskoot L; Moreno F; Barandiaran M; Sanchez-Valle R; Borroni B; Laforce R; Doré MC; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Karnath HO; Vandenberghe R; de Mendonça A; Maruta C; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Warren JD; Rohrer JD;
Appl Neuropsychol Adult; 2022; 29(1):112-119. PubMed ID: 32024404
[TBL] [Abstract][Full Text] [Related]
8. Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers.
Remnestål J; Öijerstedt L; Ullgren A; Olofsson J; Bergström S; Kultima K; Ingelsson M; Kilander L; Uhlén M; Månberg A; Graff C; Nilsson P
Transl Neurodegener; 2020 Jun; 9(1):27. PubMed ID: 32576262
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
Riancho J; Vázquez-Higuera JL; Pozueta A; Lage C; Kazimierczak M; Bravo M; Calero M; Gonalezález A; Rodríguez E; Lleó A; Sánchez-Juan P
J Alzheimers Dis; 2017; 57(2):483-491. PubMed ID: 28269782
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia.
Wilke C; Gillardon F; Deuschle C; Hobert MA; Jansen IE; Metzger FG; Heutink P; Gasser T; Maetzler W; Blauwendraat C; Synofzik M
Neurodegener Dis; 2017; 17(2-3):83-88. PubMed ID: 27760429
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia.
Rostgaard N; Waldemar G; Nielsen JE; Simonsen AH
Dement Geriatr Cogn Disord; 2015; 40(1-2):54-62. PubMed ID: 25998699
[TBL] [Abstract][Full Text] [Related]
12. Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia.
Piscopo P; Grasso M; Puopolo M; D'Acunto E; Talarico G; Crestini A; Gasparini M; Campopiano R; Gambardella S; Castellano AE; Bruno G; Denti MA; Confaloni A
J Alzheimers Dis; 2018; 65(2):455-464. PubMed ID: 30056425
[TBL] [Abstract][Full Text] [Related]
13. Plasma Exosomal miR-450b-5p as a Possible Biomarker and Therapeutic Target for Transient Ischaemic Attacks in Rats.
Luo X; Wang W; Li D; Xu C; Liao B; Li F; Zhou X; Qin W; Liu J
J Mol Neurosci; 2019 Dec; 69(4):516-526. PubMed ID: 31368061
[TBL] [Abstract][Full Text] [Related]
14. Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers.
Mohammadinasr M; Montazersaheb S; Molavi O; Kahroba H; Talebi M; Ayromlou H; Hejazi MS
Neuromolecular Med; 2023 Sep; 25(3):402-414. PubMed ID: 37020076
[TBL] [Abstract][Full Text] [Related]
15. Altered plasma protein profiles in genetic FTD - a GENFI study.
Ullgren A; Öijerstedt L; Olofsson J; Bergström S; Remnestål J; van Swieten JC; Jiskoot LC; Seelaar H; Borroni B; Sanchez-Valle R; Moreno F; Laforce R; Synofzik M; Galimberti D; Rowe JB; Masellis M; Tartaglia MC; Finger E; Vandenberghe R; de Mendonça A; Tirabosch P; Santana I; Ducharme S; Butler CR; Gerhard A; Otto M; Bouzigues A; Russell L; Swift IJ; Sogorb-Esteve A; Heller C; Rohrer JD; Månberg A; Nilsson P; Graff C;
Mol Neurodegener; 2023 Nov; 18(1):85. PubMed ID: 37968725
[TBL] [Abstract][Full Text] [Related]
16. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study.
Dopper EG; Chalos V; Ghariq E; den Heijer T; Hafkemeijer A; Jiskoot LC; de Koning I; Seelaar H; van Minkelen R; van Osch MJ; Rombouts SA; van Swieten JC
Neuroimage Clin; 2016; 12():460-5. PubMed ID: 27625986
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
[TBL] [Abstract][Full Text] [Related]
18. Serum neurofilament light chain as a surrogate of cognitive decline in sporadic and familial frontotemporal dementia.
Silva-Spínola A; Lima M; Leitão MJ; Durães J; Tábuas-Pereira M; Almeida MR; Santana I; Baldeiras I
Eur J Neurol; 2022 Jan; 29(1):36-46. PubMed ID: 34375485
[TBL] [Abstract][Full Text] [Related]
19. Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia.
van der Ende EL; Xiao M; Xu D; Poos JM; Panman JL; Jiskoot LC; Meeter LH; Dopper EG; Papma JM; Heller C; Convery R; Moore K; Bocchetta M; Neason M; Peakman G; Cash DM; Teunissen CE; Graff C; Synofzik M; Moreno F; Finger E; Sánchez-Valle R; Vandenberghe R; Laforce R; Masellis M; Tartaglia MC; Rowe JB; Butler CR; Ducharme S; Gerhard A; Danek A; Levin J; Pijnenburg YA; Otto M; Borroni B; Tagliavini F; de Mendonca A; Santana I; Galimberti D; Seelaar H; Rohrer JD; Worley PF; van Swieten JC;
J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):612-621. PubMed ID: 32273328
[TBL] [Abstract][Full Text] [Related]
20. Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort.
Russell LL; Greaves CV; Bocchetta M; Nicholas J; Convery RS; Moore K; Cash DM; van Swieten J; Jiskoot L; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Rotondo E; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Warren JD; Rohrer JD;
Cortex; 2020 Dec; 133():384-398. PubMed ID: 33221702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
